ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $10.1M invested in Entero Therapeutics in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.78M
2
+$1.31M
3
+$1.28M
4
HCM
Highbridge Capital Management
New York
+$1.01M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$867K

Top Sellers

1
-$53K
2
-$44K
3
-$43K
4
IWM
IHT Wealth Management
Illinois
-$11K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.78M
2
$1.74M
3
$1.3M
4
$1.28M
5
$1.1M
6
$1.01M
7
$730K
8
$440K
9
$417K
10
$90K
11
$54K
12
$48K
13
$46K
14
$39K
15
$10K
16
$5K
17
–